# Hyperbaric Oxygen for COVID-19 Patients

> **NCT04332081** · NA · TERMINATED · sponsor: **NYU Langone Health** · enrollment: 80 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DEVICE:** hyperbaric oxygen therapy (HBOT)

## Key facts

- **NCT ID:** NCT04332081
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-06
- **Primary completion:** 2020-05-29
- **Final completion:** 2020-05-29
- **Target enrollment:** 80 (ACTUAL)
- **Why stopped:** The IRB has determined that the design of this trial should be changed to a randomized controlled trial. A new record will be created for the redesigned study.
- **Last updated:** 2021-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04332081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04332081, "Hyperbaric Oxygen for COVID-19 Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04332081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*